ELRIG UK Unveils Keynote Speakers for Drug Discovery 2024 Conference

Keynote Speakers for Drug Discovery 2024 Conference: ELRIG UK | The Lifesciences Magazine


ELRIG UK Announces Keynote Speakers

ELRIG UK, a prominent organization within the drug discovery community, has revealed the keynote speakers for its highly anticipated Drug Discovery 2024 conference. Among the distinguished speakers are Professor Ijeoma Uchegbu FMedSci, renowned for her work in Pharmaceutical Nanoscience at University College London (UCL) and Nanomerics, and Marcus Schindler PhD, serving as Chief Scientific Officer (CSO) and Executive Vice President of Research and Early Development at Novo Nordisk.

Highlights of the Conference

Scheduled to take place from October 2–3 at ExCeL London, Drug Discovery 2024 will serve as a platform for connecting minds, transforming science, and empowering the drug discovery community. The conference, which is free to attend, promises an enriching experience for over 2,000 delegates, featuring insights from more than 100 speakers across 14 scientific tracks. These tracks, presented in collaboration with esteemed organizations like Cell & Gene Therapy Catapult and the Royal Society of Chemistry, will cover various therapeutic themes, including mechanisms of aging, cell and gene therapy, and advancements in assay design and disease modeling.

Keynote Speakers’ Profiles and Insights

Professor Uchegbu, a distinguished figure in the field, will share her expertise on the utilization of nanoparticles to enhance drug efficacy and minimize off-target effects. Her pioneering work, including the development of transformative peptide nanoparticles like Envelta™, has garnered international recognition. On the other hand, Prof. Schindler will delve into therapeutic approaches for metabolic disorders, drawing from his extensive experience in pharmaceutical research and development.

ELRIG UK Chair, Melanie Leveridge, expressed enthusiasm about the conference, highlighting the exceptional lineup of speakers and the diverse learning and networking opportunities available. Both Professor Uchegbu and Professor Schindler expressed their honor in participating as keynote speakers, emphasizing their commitment to advancing scientific knowledge and the development of innovative medicines.

In summary, Drug Discovery 2024 promises to be a pivotal event, bringing together leading experts, researchers, and industry professionals to explore the latest trends and advancements in drug discovery.

Share Now